Swallowing and Communication Outcomes Post Chemoradiotherapy for Low‐Risk Human Papillomavirus ( HPV )‐Associated Oropharyngeal Squamous Cell Carcinoma: A Substudy of TROG 12.01
Head & Neck · 2025
DOI: 10.1002/hed.28245 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Head & Neck, 2025. Verfasst von Rhys Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition & Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Chemoradiotherapy, Deglutition, Deglutition Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Background
This substudy aimed to assess swallow and communication outcomes in patients undergoing treatment for low‐risk human papillomavirus‐associated oropharyngeal squamous cell carcinoma.
Methods
Videofluoroscopy swallowing studies (VFSS) were conducted pre‐treatment, 12 and 24 months post treatment, alongside quality of life and symptom severity measures for patients receiving 70Gy radiotherapy with either weekly cisplatin or cetuximab.
Results
Of 126 patients who underwent VFSS, there were no differences in swallowing outcomes between cisplatin and cetuximab arms. VFSS outcomes were worst at 12 months and improved by 24 months, with low aspiration rates and high swallow function at all timepoints. Older age, higher T‐stage, and base of tongue tumors (versus tonsil) were associated with poorer swallowing. Clinician‐and patient‐reported speech and voice problems were minimal.
Conclusions
Swallowing was safe and efficient, and communication highly intelligible at 24 months post treatment. Both 'objective' and patient‐reported measures are important to understand the impact of new treatment approaches on swallowing‐related outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition & Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Department of Radiation Oncology, Genesis Care, Fitzroy, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
ORCID-Profile: Rhys Hughes, Jacqui Frowen
Förderung
- Medical Research Council
Zitieren
APA
Hughes, R., Corry, J., Rischin, D., Bressel, M., Kenny, L., Lehn, B., Wishart, L., Minslow, L. A., & Frowen, J. (2025). Swallowing and Communication Outcomes Post Chemoradiotherapy for Low‐Risk Human Papillomavirus ( HPV )‐Associated Oropharyngeal Squamous Cell Carcinoma: A Substudy of TROG 12.01. Head & Neck. https://doi.org/10.1002/hed.28245
Vancouver
Hughes R, Corry J, Rischin D, Bressel M, Kenny L, Lehn B, et al. Swallowing and Communication Outcomes Post Chemoradiotherapy for Low‐Risk Human Papillomavirus ( HPV )‐Associated Oropharyngeal Squamous Cell Carcinoma: A Substudy of TROG 12.01. Head & Neck. 2025. doi:10.1002/hed.28245
BibTeX
@article{Hughes2025,
author = {Hughes, Rhys and Corry, June and Rischin, Danny and Bressel, Mathias and Kenny, Lizbeth and Lehn, Belinda and Wishart, Laurelie and Minslow, Laurie-Anne and Frowen, Jacqui},
title = {Swallowing and Communication Outcomes Post Chemoradiotherapy for Low‐Risk Human Papillomavirus ( HPV )‐Associated Oropharyngeal Squamous Cell Carcinoma: A Substudy of TROG 12.01},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28245}
}
EUVIMED